Centre for Research and Innovation in Clinical Pharmaceutical Sciences

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


109 publications

In press | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2017 |
In press
 
Exploring low clozapine C/D ratios, inverted clozapine-norclozapine ratios and undetectable concentrations as measures of non-adherence in clozapine patients: A literature review and a case series of 17 patients from 3 studies.
Ruan C.J., Olmos I., Ricciardi C., Schoretsanitis G., Vincent P.D., Anıl Yağcıoğlu A.E., Eap C.B., Baptista T., Clark S.R., Fernandez-Egea E. et al. Schizophrenia research. Peer-reviewed.
[DOI][Pmid][serval:BIB_6D1104C167D0]
 
Clozapine ultrarapid metabolism during weak induction probably exists but requires careful diagnosis. A literature review, five new cases and a proposed definition.
Schoretsanitis G., Anıl Yağcıoğlu A.E., Ruan C.J., Eap C.B., Molden E., Baptista T., Clark S.R., Fernandez-Egea E., Kim S.H., Lane H.Y. et al. Schizophrenia research. Peer-reviewed.
[DOI][Pmid][serval:BIB_3AF533499666]
 
Optical Trapping and Fast Discrimination of Label-Free Bacteriophages at the Single Virion Level.
Villa N., Tartari E., Glicenstein S., de Villiers de la Noue H., Picard E., Marcoux P.R., Zelsmann M., Resch G., Hadji E., Houdré R. Small. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_26933CEB5DF3]
2024
 
Assessing the applicability and appropriateness of ChatGPT in answering clinical pharmacy questions.
Fournier A., Fallet C., Sadeghipour F., Perrottet N., 2024/05. Annales pharmaceutiques francaises, 82 (3) pp. 507-513. Peer-reviewed.
[DOI][Pmid][serval:BIB_F6682B442781]
Pharmacometric in silico studies used to facilitate a national dose standardisation process in neonatology - application to amikacin.
Gotta V., Bielicki J.A., Paioni P., Csajka C., Bräm D.S., Berger C., Giger E., Buettcher M., Posfay-Barbe K.M., Van den Anker J. et al., 2024/04/08. Swiss medical weekly, 154 p. 3632. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_9E45D3E95F65]
 
Increase of Phosphoprotein Expressions in Amotosalen/UVA-Treated Platelet Concentrates.
Muret C., Crettaz D., Alberio L., Prudent M., 2024/04. Transfusion medicine and hemotherapy, 51 (2) pp. 101-110. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2CEE9F6F46B6]
Development of a generic sample preparation method using dispersive liquid-liquid microextraction for the monitoring of leachable compounds in hospital pharmacy-prepared prefilled drug products.
Bello W., Pezzatti J., Rudaz S., Sadeghipour F., 2024/03/14. Analytical methods, 16 (11) pp. 1697-1707. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E79BEBD488A1]
 
Between Centralization and Fragmentation: The Past, Present, and Future of Phage Collections
Resch Grégory, Brives Charlotte, Debarbieux Laurent, Hodges Francesca E., Kirchhelle Claas, Laurent Frédéric, Moineau Sylvain, Martins Ana Filipa Moreira, Rohde Christine, 2024/03/01. PHAGE, 5 (1) pp. 22-29.
[DOI][WoS][serval:BIB_4802BE8FD256]
 
Phosphoproteomics and morphology of stored human red blood cells treated by protein tyrosine phosphatases inhibitor.
Bardyn M., Crettaz D., Rappaz B., Hamelin R., Armand F., Tissot J.D., Turcatti G., Prudent M., 2024/01/09. Blood advances, 8 (1) pp. 1-13. Peer-reviewed.
[DOI][Pmid][serval:BIB_19B18A3C3959]
Drug-drug interactions with oral anticoagulants: information consistency assessment of three commonly used online drug interactions databases in Switzerland.
Coumau C., Gaspar F., Terrier J., Schulthess-Lisibach A., Lutters M., Le Pogam M.A., Csajka C., 2024. Frontiers in pharmacology, 15 p. 1332147. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_ADB060660B82]
 
Editorial: Standards in personalized phage therapy: from phage collection to phage production.
Kiljunen S., Resch G., 2024. Frontiers in cellular and infection microbiology, 14 p. 1376386. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_494984BDFD46]
 
Metabolic disturbances are risk factors for readmission to psychiatric hospitals in non-smokers but not in smokers: results from a Swiss psychiatric cohort and in first-episode psychosis patients.
Laaboub N., Locatelli I., Grosu C., Piras M., Ngoc T.H., Ranjbar S., Preisig M., Elowe J., von Gunten A., Conus P. et al., 2024. Frontiers in psychiatry, 15 p. 1256416. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5AE0B514404B]
2023
 
From microbiome composition to functional engineering, one step at a time.
Burz S.D., Causevic S., Dal Co A., Dmitrijeva M., Engel P., Garrido-Sanz D., Greub G., Hapfelmeier S., Hardt W-D, Hatzimanikatis V. et al., 2023/12/20. Microbiology and molecular biology reviews, 87 (4) pp. e0006323. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_422DE1C48246]
Apixaban and rivaroxaban's physiologically-based pharmacokinetic model validation in hospitalized patients: A first step for larger use of a priori modeling approach at bed side.
Terrier J., Gaspar F., Gosselin P., Raboud O., Lenoir C., Rollason V., Csajka C., Samer C., Fontana P., Daali Y. et al., 2023/12. CPT, 12 (12) pp. 1872-1883. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_DB8C3D56D13E]
Phage activity against Staphylococcus aureus is impaired in plasma and synovial fluid.
Mutti M., Moreno D.S., Restrepo-Córdoba M., Visram Z., Resch G., Corsini L., 2023/10/24. Scientific reports, 13 (1) p. 18204. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_183FA57EA7AC]
 
Modulateurs de la protéine CFTR pour traiter la mucoviscidose
Di Paolo E.R., Mitropoulou G., Csajka C, 2023/10/06. La Gazette médicale, 12 (06) pp. 20-22.
[serval:BIB_B4DC6837999E]
Clozapine once- versus multiple-daily dosing: a two-center cross-sectional study, systematic review and meta-analysis.
Kuzo N., Haen E., Ho D.M., Takeuchi H., Piras M., Eap C.B., de Filippis R., Homan P., Kane J.M., Roy M.A. et al., 2023/10. European archives of psychiatry and clinical neuroscience, 273 (7) pp. 1567-1578. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6547F9D0CF75]
Population pharmacokinetics of apixaban in a real-life hospitalized population from the OptimAT study.
Gaspar F., Terrier J., Favre S., Gosselin P., Fontana P., Daali Y., Lenoir C., Samer C.F., Rollason V., Reny J.L. et al., 2023/10. CPT, 12 (10) pp. 1541-1552. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2BD727D8058F]
Predicting delirium in older non-intensive care unit inpatients: development and validation of the DELIrium risK Tool (DELIKT).
Schulthess-Lisibach A.E., Gallucci G., Benelli V., Kälin R., Schulthess S., Cattaneo M., Beeler P.E., Csajka C., Lutters M., 2023/10. International journal of clinical pharmacy, 45 (5) pp. 1118-1127. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_4C90B4517DE7]
 
Développements récents en hématologie, Partie 2
Duchosal Michel A., Alberio Lorenzo, Angelillo-Scherrer Anne, Arber Caroline, Balabanov Stefan, Blum Sabine, Bttcher Steffen, Buser Andreas, Cairoli Anne, Chalandon Yves et al., 2023/08/23. Forum Médical Suisse ‒ Swiss Medical Forum.
[DOI][serval:BIB_E9D38C229944]
 
Développements récents en hématologie, Teil 1
Duchosal Michel A., Alberio Lorenzo, Angelillo-Scherrer Anne, Arber Caroline, Balabanov Stefan, Blum Sabine, Bttcher Steffen, Buser Andreas, Cairoli Anne, Chalandon Yves et al., 2023/08/16. Forum Médical Suisse ‒ Swiss Medical Forum.
[DOI][serval:BIB_BEEE6D0FAED7]
Modeling tumor size dynamics based on real-world electronic health records and image data in advanced melanoma patients receiving immunotherapy.
Courlet P., Abler D., Guidi M., Girard P., Amato F., Vietti Violi N., Dietz M., Guignard N., Wicky A., Latifyan S. et al., 2023/08. CPT, 12 (8) pp. 1170-1181. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A319336A78BD]
Author Correction: Personalized aerosolised bacteriophage treatment of a chronic lung infection due to multidrug-resistant Pseudomonas aeruginosa.
Köhler T., Luscher A., Falconnet L., Resch G., McBride R., Mai Q.A., Simonin J.L., Chanson M., Maco B., Galiotto R. et al., 2023/07/24. Nature communications, 14 (1) p. 4443. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_523E349B3A6F]
 
In vitro-transfusional model for red-blood-cell study: the advantage of lowering hematocrit.
Längst E., Crettaz D., Delobel J., Renella R., Bardyn M., Turcatti G., Tissot J.D., Prudent M., 2023/07. Blood transfusion = Trasfusione del sangue, 21 (4) pp. 277-288. Peer-reviewed.
[DOI][Pmid][serval:BIB_D2AB61FF2462]
 
Modulatoren des CFTR-Proteins zur Behandlung der Mukoviszidose
Di Paolo E.R., Mitropoulou G., Csajka C., 2023/07/01. Der informierte @rtz, 13 (07) pp. 29-31.
[serval:BIB_E49900AC8E64]
Personalized aerosolised bacteriophage treatment of a chronic lung infection due to multidrug-resistant Pseudomonas aeruginosa.
Köhler T., Luscher A., Falconnet L., Resch G., McBride R., Mai Q.A., Simonin J.L., Chanson M., Maco B., Galiotto R. et al., 2023/06/27. Nature communications, 14 (1) p. 3629. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D83C8FB61C7C]
Population pharmacokinetic modelling to characterize the effect of chronic kidney disease on tenofovir exposure after tenofovir alafenamide administration.
Thoueille P., Alves Saldanha S., Desfontaine V., Kusejko K., Courlet P., Andre P., Cavassini M., Decosterd L.A., Buclin T., Guidi M. et al., 2023/06/01. The Journal of antimicrobial chemotherapy, 78 (6) pp. 1433-1443. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_449BF24E5A20]
 
The Effect of the Donor's and Recipient's Sex on Red Blood Cells Evaluated Using Transfusion Simulations.
Laengst E., Crettaz D., Tissot J.D., Prudent M., 2023/05/23. Cells, 12 (11) p. 1454. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DD94D35E0127]
Semiautomated Pipeline to Quantify Tumor Evolution From Real-World Positron Emission Tomography/Computed Tomography Imaging.
Abler D., Courlet P., Dietz M., Gatta R., Girard P., Munafo A., Wicky A., Jreige M., Guidi M., Latifyan S. et al., 2023/05. JCO clinical cancer informatics, 7 pp. e2200126. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_D61806C1E839]
 
Adapter le traitement à la situation clinique, un objectif de santé publique
Michiels Yves, 2023/03. Actualités Pharmaceutiques, 62 (624) p. 19.
[DOI][WoS][serval:BIB_E448B04D725A]
Dementia prevention in memory clinics: recommendations from the European task force for brain health services.
Frisoni G.B., Altomare D., Ribaldi F., Villain N., Brayne C., Mukadam N., Abramowicz M., Barkhof F., Berthier M., Bieler-Aeschlimann M. et al., 2023/03. The Lancet regional health. Europe, 26 p. 100576. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_46E732772F5F]
 
Prevalence of anti-tick-borne encephalitis virus (TBEV) antibodies in Swiss blood donors in 2014-2015.
Ackermann-Gäumann R., Eyer C., Vock M., Gowland P., Tinguely C., Leib S.L., Bori M., Buser A., Fontana S., Thierbach J. et al., 2023/03. Blood transfusion = Trasfusione del sangue, 21 (2) pp. 100-109. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7B01A2676532]
Vision and practice of self-care for community pharmacy in Switzerland.
Amador-Fernández N., Jenkinson S.P., Berger J., 2023/03. Exploratory research in clinical and social pharmacy, 9 p. 100253. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_22135134B970]
 
Erratum to 'Drug-Drug Interactions with Direct Oral Anticoagulants: Practical Recommendations for Clinicians' The American Journal of Medicine, Volume 134 (2021), Issue 8, 939-942.
Terrier J., Gaspar F., Fontana P., Daali Y., Reny J.L., Csajka C., Samer C.F., 2023/02. The American journal of medicine, 136 (2) pp. 216-217. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6D9C337CCB7A]
Adherence to the CDK 4/6 Inhibitor Palbociclib and Omission of Dose Management Supported by Pharmacometric Modelling as Part of the OpTAT Study.
Bandiera C., Locatelli I., Courlet P., Cardoso E., Zaman K., Stravodimou A., Dolcan A., Sarivalasis A., Zurcher J.P., Aedo-Lopez V. et al., 2023/01/03. Cancers, 15 (1) p. 316. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2263B25B85EB]
Evolutions of Metabolic Parameters Following Switches of Psychotropic Drugs: A Longitudinal Cohort Study.
Piras M., Ranjbar S., Laaboub N., Grosu C., Gamma F., Plessen K.J., von Gunten A., Conus P., Eap C.B., 2023/01/03. Schizophrenia bulletin, 49 (1) pp. 24-33. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_4FD18F26D483]
 
An interprofessional medication adherence program to optimize adherence to oral anticancer therapies: a randomized-controlled trial
Bandiera C., Cardoso E., Locatelli I., Digklia A., Zaman K., Diciolla A., Cristina V., Stravodimou A., Lopez V.A., Dolcan A. et al., 2023., 26th International Society for Medication Adherence (ESPACOMP) Conference p. 269 dans International Journal of Clinical Pharmacy. Peer-reviewed.
[DOI][Pmid][serval:BIB_944A7B3041CF]
Evaluation of an enhanced service for medication review with follow up in Swiss community pharmacies: Pre-post study protocol.
Amador-Fernández N., Escaith M., Simi E., Quintana-Bárcena P., Berger J., 2023. PloS one, 18 (10) pp. e0292037. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_68FC8E562AB9]
From personalized to precision medicine in oncology: A model-based dosing approach to optimize achievement of imatinib target exposure.
Goutelle S., Guidi M., Gotta V., Csajka C., Buclin T., Widmer N., 2023. Pharmaceutics, 15 (4) p. 1081. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_829AAAA406A8]
Infant exposure to Fluvoxamine through placenta and human milk: a case series - A contribution from the ConcePTION project.
Monfort A., Cardoso E., Eap C.B., Fischer Fumeaux C.J., Graz M.B., Morisod Harari M., Weisskopf E., Gandia P., Allegaert K., Nordeng H. et al., 2023. Frontiers in psychiatry, 14 p. 1167870. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_EE8A9936EA15]
 
Maternal drugs and breastfeeding: Risk assessment from pharmacokinetics to safety evidence - A contribution from the ConcePTION project.
Cardoso E., Monfort A., Ferreira E., Nordeng H., Winterfeld U., Allegaert K., Gandia P., Guidi M., Panchaud A., 2023. Therapie, 78 (2) pp. 149-156. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_616A71B2E82E]
Precision oncology by point-of-care therapeutic drug monitoring and dosage adjustment of conventional cytotoxic chemotherapies: A perspective.
Briki M., André P., Thoma Y., Widmer N., Wagner A.D., Decosterd L.A., Buclin T., Guidi M., Carrara S., 2023. Pharmaceutics, 15 (4) p. 1283. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A82A8DDE8796]
2022
Phage therapy for pulmonary infections: lessons from clinical experiences and key considerations.
Mitropoulou G., Koutsokera A., Csajka C., Blanchon S., Sauty A., Brunet J.F., von Garnier C., Resch G., Guery B., 2022/12/31. European respiratory review, 31 (166) p. 220121. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E890AE6D6C1D]
Clinical predictors of antipsychotic treatment resistance: Development and internal validation of a prognostic prediction model by the STRATA-G consortium.
Smart S.E., Agbedjro D., Pardiñas A.F., Ajnakina O., Alameda L., Andreassen O.A., Barnes TRE, Berardi D., Camporesi S., Cleusix M. et al., 2022/12. Schizophrenia research, 250 pp. 1-9. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_FD83206AB9D6]
Population pharmacokinetic analyses of regorafenib and capecitabine in patients with locally advanced rectal cancer (SAKK 41/16 RECAP).
Schmulenson E., Bovet C., Theurillat R., Decosterd L.A., Largiadèr C.R., Prost J.C., Csajka C., Bärtschi D., Guckenberger M., von Moos R. et al., 2022/12. British journal of clinical pharmacology, 88 (12) pp. 5336-5347. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_FD41EC93A336]
Evolution of Blood Safety in Switzerland over the Last 25 Years for HIV, HCV, HBV and Treponema pallidum.
Niederhauser C., Tinguely C., Stolz M., Vock M., El Dusouqui S.A., Gowland P., 2022/11/23. Viruses, 14 (12) p. 2611. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2EAB3C0FF111]
 
Phagothérapie pour traiter les infections respiratoires [Phage therapy for respiratory infections]
Mitropoulou G., Gijs P.J., Koutsokera A., Sauty A., Blanchon S., Csajka C., Brunet J.F., Resch G., Guery B., Von Garnier C., 2022/11/16. Revue medicale suisse, 18 (804) pp. 2150-2156. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_CCFF1CBAD0AE]
 
Automatic Detection of Adverse Drug Events in Geriatric Care: Study Proposal.
Gaspar F., Lutters M., Beeler P.E., Lang P.O., Burnand B., Rinaldi F., Lovis C., Csajka C., Le Pogam M.A., SwissMADE study, 2022/11/15. JMIR research protocols, 11 (11) pp. e40456. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0A5F29ECD8BC]
Identification and Characterization of Erwinia Phage IT22: A New Bacteriophage-Based Biocontrol against Erwinia amylovora.
Sabri M., El Handi K., Valentini F., De Stradis A., Achbani E.H., Benkirane R., Resch G., Elbeaino T., 2022/11/05. Viruses, 14 (11). Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0DD606476BEB]
 
Antibody response and intra-host viral evolution after plasma therapy in COVID-19 patients pre-exposed or not to B-cell-depleting agents.
Gachoud D., Pillonel T., Tsilimidos G., Battolla D., Dumas D., Opota O., Fontana S., Vollenweider P., Manuel O., Greub G. et al., 2022/11. British journal of haematology, 199 (4) pp. 549-559. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_801AF06A907A]
Evaluation of the association of anticholinergic burden and delirium in older hospitalised patients - A cohort study comparing 19 anticholinergic burden scales.
Lisibach A., Gallucci G., Benelli V., Kälin R., Schulthess S., Beeler P.E., Csajka C., Lutters M., 2022/11. British journal of clinical pharmacology, 88 (11) pp. 4915-4927. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_4DDB0E74DD7C]
Impact of Pharmaceutical Interventions with STOPP/START and PIM-Check in Older Hospitalized Patients: A Randomized Controlled Trial.
Farhat A., Al-Hajje A., Lang P.O., Csajka C., 2022/11. Drugs & aging, 39 (11) pp. 899-910. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_570B94333C1E]
 
Two novel platelet biotinylation methods and their impact on stored platelet concentrates in a blood bank environment.
Muret C., Crettaz D., Martin A., Aliotta A., Bertaggia Calderara D., Alberio L., Prudent M., 2022/11. Transfusion, 62 (11) pp. 2324-2333. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FEDC4542E651]
Implementation and Cross-Validation of a Pharmacokinetic Model for Precision Dosing of Busulfan in Hematopoietic Stem Cell Transplanted Children.
Goutelle S., Thoma Y., Buffet R., Philippe M., Buclin T., Guidi M., Csajka C., 2022/10/01. Pharmaceutics, 14 (10) p. 2107. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_1F77B194CA9D]
Effect of Mercury on Membrane Proteins, Anionic Transport and Cell Morphology in Human Erythrocytes.
Notariale R., Längst E., Perrone P., Crettaz D., Prudent M., Manna C., 2022/09/21. Cellular physiology and biochemistry, 56 (5) pp. 500-513. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_1C35A85AD818]
 
Exposure-Response Analysis of Osimertinib in Patients with Advanced Non-Small-Cell Lung Cancer.
Rodier T., Puszkiel A., Cardoso E., Balakirouchenane D., Narjoz C., Arrondeau J., Fallet V., Khoudour N., Guidi M., Vidal M. et al., 2022/09/01. Pharmaceutics, 14 (9) p. 1844. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_72EF703BC03A]
Population Pharmacokinetic Models for Direct Oral Anticoagulants: A Systematic Review and Clinical Appraisal Using Exposure Simulation.
Terrier J., Gaspar F., Guidi M., Fontana P., Daali Y., Csajka C., Reny J.L., 2022/08. Clinical pharmacology and therapeutics, 112 (2) pp. 353-363. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2F23BCB64F8E]
Real-Life Therapeutic Concentration Monitoring of Long-Acting Cabotegravir and Rilpivirine: Preliminary Results of an Ongoing Prospective Observational Study in Switzerland.
Thoueille P., Alves Saldanha S., Schaller F., Munting A., Cavassini M., Braun D., Günthard H.F., Kusejko K., Surial B., Furrer H. et al., 2022/07/29. Pharmaceutics, 14 (8) p. 1588. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_EA4A25E4F31E]
Personalized bacteriophage therapy to treat pandrug-resistant spinal Pseudomonas aeruginosa infection.
Ferry T., Kolenda C., Laurent F., Leboucher G., Merabischvilli M., Djebara S., Gustave C.A., Perpoint T., Barrey C., Pirnay J.P. et al., 2022/07/22. Nature communications, 13 (1) p. 4239. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_7F7461B53275]
 
Antioxidants in single methylene-blue-treated plasma units cannot be used to predict pathogen inactivation treatment success.
Lotens A., Prudent M., Rapaille A., 2022/07. Vox sanguinis, 117 (7) pp. 937-942. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9A3B60FFAD81]
Enantiospecific pharmacokinetics of intravenous dexmedetomidine in beagles.
Levionnois O.L., Barbarossa A., Bardhi A., Siegenthaler J., Forss Pleyers T., Guidi M., Spadavecchia C., Raillard M., 2022/07. Journal of veterinary pharmacology and therapeutics, 45 (4) pp. 366-372. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F2C44CF39F4A]
Population Pharmacokinetics of Palbociclib and Its Correlation with Clinical Efficacy and Safety in Patients with Advanced Breast Cancer.
Courlet P., Cardoso E., Bandiera C., Stravodimou A., Zurcher J.P., Chtioui H., Locatelli I., Decosterd L.A., Darnaud L., Blanchet B. et al., 2022/06/21. Pharmaceutics, 14 (7) p. 1317. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E7FBC59504B2]
Insomnia disorders are associated with increased cardiometabolic disturbances and death risks from cardiovascular diseases in psychiatric patients treated with weight-gain-inducing psychotropic drugs: results from a Swiss cohort.
Laaboub N., Dubath C., Ranjbar S., Sibailly G., Grosu C., Piras M., Délessert D., Richard-Lepouriel H., Ansermot N., Crettol S. et al., 2022/05/17. BMC psychiatry, 22 (1) p. 342. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2E9824076089]
 
Interventions to support adherence to oral anticancer therapies: research challenges, lessons learned, and strategies to overcome them from Australia and Switzerland.
Bandiera C., Skrabal Ross X., Cardoso E., Wagner D., Csajka C., Olver I., Patterson P., Suppiah V., Gunn K.M., Schneider M., 2022/05. Supportive care in cancer, 30 (5) pp. 3655-3659. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4F808DD17629]
Model-based meta-analysis of salbutamol pharmacokinetics and practical implications for doping control.
Courlet P., Buclin T., Biollaz J., Mazzoni I., Rabin O., Guidi M., 2022/04. CPT, 11 (4) pp. 469-481. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F6F9604D8FA0]
Presence of autoantibodies in serum does not impact the occurrence of immune checkpoint inhibitor-induced hepatitis in a prospective cohort of cancer patients.
Purde M.T., Niederer R., Wagner N.B., Diem S., Berner F., Hasan Ali O., Hillmann D., Bergamin I., Joerger M., Risch M. et al., 2022/03. Journal of cancer research and clinical oncology, 148 (3) pp. 647-656. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_55D7AEBA3688]
Dosing strategies of imipenem in neonates based on pharmacometric modelling and simulation.
Dao K., Fuchs A., André P., Giannoni E., Decosterd L.A., Marchetti O., Asner S.A., Pfister M., Widmer N., Buclin T. et al., 2022/02/02. The Journal of antimicrobial chemotherapy, 77 (2) pp. 457-465. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6EBEF14704F8]
Bacteriophages Combined With Subtherapeutic Doses of Flucloxacillin Act Synergistically Against Staphylococcus aureus Experimental Infective Endocarditis.
Save J., Que Y.A., Entenza J.M., Kolenda C., Laurent F., Resch G., 2022/02. Journal of the American Heart Association, 11 (3) pp. e023080. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_28CEC1719C12]
High anticholinergic burden at admission associated with in-hospital mortality in older patients: A comparison of 19 different anticholinergic burden scales.
Lisibach A., Gallucci G., Beeler P.E., Csajka C., Lutters M., 2022/02. Basic & clinical pharmacology & toxicology, 130 (2) pp. 288-300. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_5C4A662F2F17]
 
Parametric and Nonparametric Methods in Population Pharmacokinetics: Experts' Discussion on Use, Strengths, and Limitations.
Goutelle S., Woillard J.B., Buclin T., Bourguignon L., Yamada W., Csajka C., Neely M., Guidi M., 2022/02. Journal of clinical pharmacology, 62 (2) pp. 158-170. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E083EEFD4CCE]
 
Parametric Approaches in Population Pharmacokinetics.
Guidi M., Csajka C., Buclin T., 2022/02. Journal of clinical pharmacology, 62 (2) pp. 125-141. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4AEA287B02AD]
Pédiatrie - Accès au lait de donneuses en Suisse et création de la première banque de lait maternel romande au CHUV : enjeux et perspectives [Access to donor human milk in Switzerland and CHUV's first human milk bank in Romandy : issues and perspectives]
Fischer Fumeaux C.J., Barin J., Prudent M., Richard C., Martin A., Henriot I., Legardeur H., Kaech C., May H., Vuignier J. et al., 2022/01/19. Revue medicale suisse, 18 (764-5) pp. 59-63. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_52AE47FB217E]
 
Recent progress toward the implementation of phage therapy in Western medicine.
Pirnay J.P., Ferry T., Resch G., 2022/01/18. FEMS microbiology reviews, 46 (1) pp. fuab040. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_BDE03CF6EB6D]
A Dynamic Constraint-based Modelling (DCBM) Approach With Alternative Metabolic Objective Functions Predicts The impact of Oxidative Stress on Stored Red Blood Cells (RBCs)
Yasemi M., Prudent M., Jolicoeur M., 2022. IFAC-PapersOnLine, 55 (20) pp. 385-390. Peer-reviewed.
[URN][DOI][WoS][serval:BIB_76D1B115F65A]
Efficacy assessment of a novel endolysin PlyAZ3aT for the treatment of ceftriaxone-resistant pneumococcal meningitis in an infant rat model.
Valente L.G., Le N.D., Pitton M., Chiffi G., Grandgirard D., Jakob S.M., Cameron D.R., Resch G., Que Y.A., Leib S.L., 2022. PloS one, 17 (4) pp. e0266928. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A33C7C8026C9]
Medication Adherence Evaluated Through Electronic Monitors During the 2020 COVID-19 Pandemic Lockdown in Switzerland: A Longitudinal Analysis.
Bandiera C., Pasquier J., Locatelli I., Niquille A., Wuerzner G., Dotta-Celio J., Hachfeld A., Wandeler G., Wagner A.D., Csajka C. et al., 2022. Patient preference and adherence, 16 pp. 2313-2320. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_813F43A545D0]
Swiss Priority Setting on Implementing Medication Adherence Interventions as Part of the European ENABLE COST Action.
Bandiera C., Ribaut J., Dima A.L., Allemann S.S., Molesworth K., Kalumiya K., Käser F., Olson M.S., Burnier M., van Boven JFM et al., 2022. International journal of public health, 67 p. 1605204. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9A9F2371DDD2]
2021
 
Investigating the Relations Between Caffeine-Derived Metabolites and Plasma Lipids in 2 Population-Based Studies.
Petrovic D., Pruijm M., Ponte B., Dhayat N.A., Ackermann D., Ehret G., Ansermot N., Vogt B., Martin P.Y., Stringhini S. et al., 2021/12. Mayo Clinic proceedings, 96 (12) pp. 3071-3085. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_96BE60BE6909]
Ability to detect potentially inappropriate prescribing in older patients: comparative analysis between PIM-Check and STOPP/STARTv2.
Farhat A., Panchaud A., Al-Hajje A., Lang P.O., Csajka C., 2021/11. European journal of clinical pharmacology, 77 (11) pp. 1747-1756. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F1DB8BDAA204]
Effect of Quetiapine, from Low to High Dose, on Weight and Metabolic Traits: Results from a Prospective Cohort Study.
Dubath C., Piras M., Gholam M., Laaboub N., Grosu C., Sentissi O., Gamma F., Solida A., von Gunten A., Conus P. et al., 2021/11. Pharmacopsychiatry, 54 (6) pp. 279-286. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_615A39552FB8]
Metabolomic alteration induced by psychotropic drugs: Short-term metabolite profile as a predictor of weight gain evolution.
Lenski M., Sidibé J., Gholam M., Hennart B., Dubath C., Augsburger M., von Gunten A., Conus P., Allorge D., Thomas A. et al., 2021/11. Clinical and translational science, 14 (6) pp. 2544-2555. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_B399E4FCFB6A]
 
Pharmacokinetic parameters and weight change in HIV patients newly switched to dolutegravir-based regimens in SIMPL'HIV clinical trial.
Courlet P., Barbieux C., Sculier D., Wandeler G., Stoeckle M., Bernasconi E., Braun D., Vernazza P., Cavassini M., Marinosci A. et al., 2021/11. British journal of clinical pharmacology, 87 (11) pp. 4455-4460. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_87880AB3A5A2]
 
Storage of red blood cell concentrates: Clinical impact.
Längst E., Tissot J.D., Prudent M., 2021/11. Transfusion clinique et biologique, 28 (4) pp. 397-402. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4170D4BD671F]
 
Unpuzzling Friunavirus-Host Interactions One Piece at a Time: Phage Recognizes Acinetobacter pittii via a New K38 Capsule Depolymerase.
Domingues R., Barbosa A., Santos S.B., Pires D.P., Save J., Resch G., Azeredo J., Oliveira H., 2021/10/26. Antibiotics, 10 (11) p. 1304. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F188454F68EC]
Protocols for cognitive enhancement. A user manual for Brain Health Services-part 5 of 6.
Brioschi Guevara A., Bieler M., Altomare D., Berthier M., Csajka C., Dautricourt S., Démonet J.F., Dodich A., Frisoni G.B., Miniussi C. et al., 2021/10/11. Alzheimer's research & therapy, 13 (1) p. 172. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_F39EC11590C2]
 
Phase I Dose-Escalation Study of the Dual PI3K-mTORC1/2 Inhibitor Gedatolisib in Combination with Paclitaxel and Carboplatin in Patients with Advanced Solid Tumors.
Colombo I., Genta S., Martorana F., Guidi M., Frattini M., Samartzis E.P., Brandt S., Gaggetta S., Moser L., Pascale M. et al., 2021/09/15. Clinical cancer research, 27 (18) pp. 5012-5019. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F48454275B82]
 
Clinical and economic impacts of explicit tools detecting prescribing errors: A systematic review.
Farhat A., Al-Hajje A., Csajka C., Panchaud A., 2021/08. Journal of clinical pharmacy and therapeutics, 46 (4) pp. 877-886. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E9B3E8C32619]
 
Drug-Drug Interactions with Direct Oral Anticoagulants: Practical Recommendations for Clinicians.
Terrier J., Gaspar F., Fontana P., Youssef D., Reny J.L., Csajka C., Samer C.F., 2021/08. The American journal of medicine, 134 (8) pp. 939-942. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4ADAFEEDAF54]
 
Once-daily 1 g ceftriaxone optimizes exposure in patients with septic shock and hypoalbuminemia receiving continuous veno-venous hemodiafiltration.
Ulldemolins M., Bastida C., Llauradó-Serra M., Csajka C., Rodríguez A., Badia J.R., Martín-Loeches I., Soy D., 2021/08. European journal of clinical pharmacology, 77 (8) pp. 1169-1180. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F72758826E29]
Complete Genome Sequence of Pseudomonas Phage Zikora.
Ezemokwe C.G., Agwom F.M., Okoliegbe I., Okonkwo F.O., Ngene A.C., Gimba N., Morenikeji O.R., Egwuenu A., Okonkwo C.H., Aguiyi J.C. et al., 2021/07/29. Microbiology resource announcements, 10 (30) pp. e0048921. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_62D87F751BD6]
 
Hypoxia and hypocapnia storage of γ-irradiated red cell concentrates.
Bardyn M., Crettaz D., Borlet M., Längst E., Martin A., Abonnenc M., Tissot J.D., Dunham A., Yoshida T., Prudent M., 2021/07. Blood transfusion = Trasfusione del sangue, 19 (4) pp. 300-308. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4338B49A63C1]
Population pharmacokinetic modelling to quantify the magnitude of drug-drug interactions between amlodipine and antiretroviral drugs.
Courlet P., Guidi M., Alves Saldanha S., Cavassini M., Stoeckle M., Buclin T., Marzolini C., Decosterd L.A., Csajka C., 2021/07. European journal of clinical pharmacology, 77 (7) pp. 979-987. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_DCBBE5FFBE88]
 
The role of cytochrome P450 enzyme genetic variants in cannabis hyperemesis syndrome-A case report.
Kuzin M., Xepapadakos F., Scharrer I., Augsburger M., Eap C.B., Schoretsanitis G., 2021/07. Basic & clinical pharmacology & toxicology, 129 (1) pp. 82-85. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_14FE5ED0F763]
Image- and Fluorescence-Based Test Shows Oxidant-Dependent Damages in Red Blood Cells and Enables Screening of Potential Protective Molecules.
Bardyn M., Allard J., Crettaz D., Rappaz B., Turcatti G., Tissot J.D., Prudent M., 2021/04/20. International journal of molecular sciences, 22 (8) p. 4293. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_5D01C543DB17]
Pharmacokinetic/Pharmacodynamic Modelling to Describe the Cholesterol Lowering Effect of Rosuvastatin in People Living with HIV.
Courlet P., Guidi M., Alves Saldanha S., Stader F., Traytel A., Cavassini M., Stoeckle M., Buclin T., Marzolini C., Decosterd L.A. et al., 2021/03. Clinical pharmacokinetics, 60 (3) pp. 379-390. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CF76FDD25628]
Quality of anticholinergic burden scales and their impact on clinical outcomes: a systematic review.
Lisibach A., Benelli V., Ceppi M.G., Waldner-Knogler K., Csajka C., Lutters M., 2021/02. European journal of clinical pharmacology, 77 (2) pp. 147-162. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_BFD95CBADD31]
 
Automated Detection of Adverse Drug Events from Older Patients' Electronic Medical Records Using Text Mining
Colic Nicola, Beeler Patrick, Csajka Chantal, Foufi Vasiliki, Gaspar Frederic, Pogam Marie-Annick Le, Lisibach Angela, Lovis Christian, Lutters Monika, Rinaldi Fabio, 2021. pp. 203-211 dans Pattern Recognition. ICPR International Workshops and Challenges, Springer International Publishing.
[DOI][serval:BIB_0EBA03943A2C]
Elevated acute phase proteins affect pharmacokinetics in COVID-19 trials: Lessons from the CounterCOVID - imatinib study.
Bartelink I.H., Bet P.M., Widmer N., Guidi M., Duijvelaar E., Grob B., Honeywell R., Evelo A., Tielbeek IPE, Snape S.D. et al., 2021. CPT, 10 (12) pp. 1497-1511. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_1F1A8DF39680]
Impact of Pharmaceutical Interventions in Hospitalized Patients: A Comparative Study Between Clinical Pharmacists and an Explicit Criteria-Based Tool.
Farhat A., Abou-Karroum R., Panchaud A., Csajka C., Al-Hajje A., 2021. Current therapeutic research, clinical and experimental, 95 p. 100650. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_468B1ED3F169]
 
Optimizing oral targeted anticancer therapies study for patients with solid cancer: Protocol for a randomized controlled medication adherence program along with systematic collection and modeling of pharmacokinetic and pharmacodynamic data.
Bandiera C., Cardoso E., Locatelli I., Digklia A., Zaman K., Diciolla A., Cristina V., Stravodimou A., Lopez V.A., Dolcan A. et al., 2021. JMIR research protocols, 10 (6) pp. e30090. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7657CD7990C9]
2020
Enquête « RTO-COVID-19 » : nos soins, nos actions, leurs effets
Graz B., Houriet J., Willcox M., Csajka C., 2020/08/26. Revue medicale suisse, 16 (703) pp. 1522-1523. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_08A6DD2A517F]
 
A population pharmacokinetic model for escitalopram and its major metabolite in depressive patients during the perinatal period: Prediction of infant drug exposure through breast milk.
Weisskopf E., Guidi M., Fischer C.J., Bickle Graz M., Beaufils E., Nguyen K.A., Morisod Harari M., Rouiller S., Rothenburger S., Gaucherand P. et al., 2020/08. British journal of clinical pharmacology, 86 (8) pp. 1642-1653. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6EA0D4637119]
Influence of Drug-Drug Interactions on the Pharmacokinetics of Atorvastatin and Its Major Active Metabolite ortho-OH-Atorvastatin in Aging People Living with HIV.
Courlet P., Decosterd L.A., Alves Saldanha S., Cavassini M., Stader F., Stoeckle M., Buclin T., Marzolini C., Csajka C., Guidi M. et al., 2020/08. Clinical pharmacokinetics, 59 (8) pp. 1037-1048. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_B56252981556]
 
Population Pharmacokinetics of Erlotinib in Patients With Non-small Cell Lung Cancer: Its Application for Individualized Dosing Regimens in Older Patients.
Cardoso E., Guidi M., Khoudour N., Boudou-Rouquette P., Fabre E., Tlemsani C., Arrondeau J., Goldwasser F., Vidal M., Schneider M.P. et al., 2020/07. Clinical therapeutics, 42 (7) pp. 1302-1316. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C945C7298567]
 
Stability of N-Acetylcysteine (NAC) in Standardized Pediatric Parenteral Nutrition and Evaluation of N,N-Diacetylcystine (DAC) Formation.
Sommer I., Schwebel H., Adamo V., Bonnabry P., Bouchoud L., Sadeghipour F., 2020/06/21. Nutrients, 12 (6) p. 1849. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B3A77814E178]
Population Pharmacokinetics/Pharmacodynamics of Dabrafenib Plus Trametinib in Patients with BRAF-Mutated Metastatic Melanoma.
Balakirouchenane D., Guégan S., Csajka C., Jouinot A., Heidelberger V., Puszkiel A., Zehou O., Khoudour N., Courlet P., Kramkimel N. et al., 2020/04/09. Cancers, 12 (4). Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_E1BBC7ED0901]
2019
 
Towards Personalized Antithrombotic Treatments: Focus on P2Y<sub>12</sub> Inhibitors and Direct Oral Anticoagulants.
Terrier J., Daali Y., Fontana P., Csajka C., Reny J.L., 2019/12. Clinical pharmacokinetics, 58 (12) pp. 1517-1532. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_AC8A16216FE8]
2017
 
Prevalence of polypharmacy in the Swiss HIV Cohort Study (SHCS). Le futur c’est maintenant !
Courlet P., Cavassini M., Choong E., Csajka C., Marzolini C., Decosterd L., and the Swiss HIV Cohort Study, 2017/05/03. dans SSMIG SSPTC Spring Meeting, Lausanne EPFL.
[serval:BIB_DFA2081D36EE]
 
Optimiser ses prescriptions : quelle démarche et quel outil ?
Lang P.O., Farhat A., Csajka C., 2017/04/01. Revue de Geriatrie, 42 (4) pp. 207-218. Peer-reviewed.
[serval:BIB_A3E1CDE63ACA]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University